Condition: Esophageal Cancer
Interventions: Radiation: Involved field irradiation; Radiation: Elective field irradiation; Drug: Paclitaxel; Drug: Lobaplatin; Drug: PEG-rhG-CSF
Sponsors: Chinese Academy of Medical Sciences; The First Affiliated Hospital with Nanjing Medical University; Tianjin Medical University Cancer Institute and Hospital; Anyang Cancer Hospital; Fujian Cancer Hospital; Beijing Cancer Hospital; Hebei Medical University Fourth Hospital
Recruiting
https://ift.tt/2PPJPHL
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου